NXXT vs NXTC: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

NXTC has stronger fundamentals based on our AI analysis.

NXXT
NEXTNRG, INC.
STRONG SELL
97%
Confidence
VS
NXTC
NextCure, Inc.
SELL
78%
Confidence

NXXT vs NXTC Fundamental Comparison

Metric NXXT NXTC
Revenue $58.8M $22.4M
Net Income $-59.1M $-55.8M
Net Margin -100.5% -249.5%
ROE N/A -159.8%
ROA -300.9% -111.3%
Current Ratio 0.13x 4.14x
Debt/Equity N/A 0.00x
EPS $-0.51 $-19.65

Green = Better metric | Red = Weaker metric

View Full NXXT Analysis →
View Full NXTC Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

NXXT vs AAPL NXTC vs MSFT NXXT vs GOOGL NXTC vs AMZN

NXXT vs NXTC: Frequently Asked Questions

Is NXXT or NXTC a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), NXTC has stronger fundamentals. NXXT is rated STRONG SELL (97% confidence) while NXTC is rated SELL (78% confidence). This is not investment advice.

How does NXXT compare to NXTC fundamentally?

NEXTNRG, INC. has ROE of N/A vs NextCure, Inc.'s -159.8%. Net margins are -100.5% vs -249.5% respectively.

Which stock pays higher dividends, NXXT or NXTC?

NXXT has a dividend yield of N/A or no dividend while NXTC has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in NXXT or NXTC for long term?

For long-term investing, consider that NXXT has STRONG SELL rating with 97% confidence, while NXTC has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about NXXT vs NXTC?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NXXT vs NXTC, the AI consensus favors NXTC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.